151 related articles for article (PubMed ID: 9117480)
1. Long-term psychiatric patients' knowledge about their medication.
Tempier R
Psychiatr Serv; 1996 Dec; 47(12):1385-7. PubMed ID: 9117480
[TBL] [Abstract][Full Text] [Related]
2. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
3. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
4. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Psychoeducation on Long-term Inpatients with Schizophrenia and Schizoaffective Disorder.
Yanagida N; Uchino T; Uchimura N
Kurume Med J; 2017 May; 63(3.4):61-67. PubMed ID: 28381728
[TBL] [Abstract][Full Text] [Related]
6. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
[TBL] [Abstract][Full Text] [Related]
8. Impact of Psychoeducation on Knowledge of and Attitude Toward Medications in Clients With Schizophrenia and Schizoaffective Disorders.
Choe K; Sung BJ; Kang Y; Yoo SY
Perspect Psychiatr Care; 2016 Apr; 52(2):113-9. PubMed ID: 25640073
[TBL] [Abstract][Full Text] [Related]
9. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
[TBL] [Abstract][Full Text] [Related]
10. [Can psycho-education of chronic schizophrenic patients have a short-term effect on drug-related attitude and behavior?].
Hornung WP; Franzen U; Lemke R; Wiesemann C; Buchkremer G
Psychiatr Prax; 1993 Jul; 20(4):152-4. PubMed ID: 8103230
[TBL] [Abstract][Full Text] [Related]
11. Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2010; 71 Suppl 2():20-6. PubMed ID: 21190649
[TBL] [Abstract][Full Text] [Related]
12. [Psychopharmacological treatment: patients' knowledge about their medication].
Zanieri G; Buizza C; Ravelli L; Bignotti S; Porteri C; Pioli R; Saltini A
Recenti Prog Med; 2003 Sep; 94(9):387-90. PubMed ID: 12942800
[TBL] [Abstract][Full Text] [Related]
13. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
14. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
Diaz E; Levine HB; Sullivan MC; Sernyak MJ; Hawkins KA; Cramer JA; Woods SW
J Psychiatry Neurosci; 2001 Sep; 26(4):325-9. PubMed ID: 11590972
[TBL] [Abstract][Full Text] [Related]
15. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
Hornung WP; Schonauer K; Feldmann R; Mönking HS
Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
[TBL] [Abstract][Full Text] [Related]
16. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
Hornung WP; Buchkremer G; Redbrake M; Klingberg S
Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic medication adherence: is there a difference between typical and atypical agents?
Dolder CR; Lacro JP; Dunn LB; Jeste DV
Am J Psychiatry; 2002 Jan; 159(1):103-8. PubMed ID: 11772697
[TBL] [Abstract][Full Text] [Related]
18. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
Morrissette DA; Stahl SM
CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
[TBL] [Abstract][Full Text] [Related]
19. Long-acting risperidone in young adults with early schizophrenia or schizoaffective illness.
Lasser RA; Bossie CA; Zhu Y; Locklear JC; Kane JM
Ann Clin Psychiatry; 2007; 19(2):65-71. PubMed ID: 17612845
[TBL] [Abstract][Full Text] [Related]
20. Treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
